AI-generated summary
The authors report a double-blind, placebo-controlled trial of low-level laser therapy in 79 patients with mild to moderate carpal tunnel syndrome. Compared with a sham laser group, the active laser group showed reduced pain, fewer positive Tinel's signs and shorter nerve latencies over the short term, which the authors describe as statistically significant.
- Participants
- 79
- Who or what was studied
- Patients with mild to moderate carpal tunnel syndrome lasting less than one year
- Wavelengths
- 780 nm
- Limits stated in the abstract
- The abstract reports only short-term follow-up, three weeks after the last treatment, in a single study of 79 patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 780 nm
- Power
- 30 mW
- Total energy
- 2.7 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Placebo-controlled, Visual analogue scale, Control group, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.